About Kyra Medical
Kyra Medical is a private company based in Northborough, Massachusetts. It has reported $8,434,958 raised in 12 offerings on Form D since January 2017. Its chief executive is Howard Miller.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 31, 2024 | Jun 13, 2024amended Jun 13, 2024 | $1,186,176of $1.2M target | 14 | $84,727 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jul 1, 2023 | Jul 17, 2023 | $173,012fully sold | 14 | $12,358 | EquityRule 506(b) | Form D ↗ |
| Jul 1, 2023 | Jul 14, 2023 | $2,600,745fully sold | 14 | $185K | Convertible promissory notesRule 506(b) | Form D ↗ |
| Mar 10, 2022 | Mar 24, 2022amended Sep 21, 2022 | $1,210,156of $2.1M target | 11 | $110K | DebtRule 506(b) | Form D/A ↗1 earlier filing |
| Apr 3, 2020 | Apr 15, 2020amended Nov 2, 2020 | $799,983of $800K target | 10 | $79,998 | EquityRule 506(b) | Form D/A ↗3 earlier filings |
| Jan 15, 2020 | Jan 28, 2020 | $100,000fully sold | 1 | $100K | DebtRule 506(b) | Form D ↗ |
| Dec 12, 2019 | Dec 23, 2019 | $164,886fully sold | 4 | $41,222 | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 7, 2019 | Jun 26, 2019 | $200,000of $250K target | 6 | $33,333 | DebtRule 506(b) | Form D ↗ |
| Feb 26, 2018 | Mar 9, 2018 | $400,000of $1.0M target | 2 | $200K | EquityRule 506(b) | Form D ↗ |
| Aug 17, 2017 | Aug 30, 2017 | $325,000of $625K target | 4 | $81,250 | Equity, DebtRule 506(b) | Form D ↗ |
| Apr 20, 2017 | May 4, 2017amended Jun 15, 2017 | $625,000fully sold | 23 | $27,174 | Convertible notesRule 506(b) | Form D/A ↗1 earlier filing |
| Oct 7, 2016 | Jan 3, 2017 | $650,000fully sold | 10 | $65,000 | EquityRule 506(b) | Form D ↗ |
| Total, 12 offerings | $8,434,958 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Kyra Medical's Form D filed Jun 13, 2024.
ET
Erik Tuveson
Director
HM
Howard Miller
President; Chief Executive Officer and director
JD
Jesse Drake
Chief Operating Officer and director
Earlier filings also listed Tom Skripps (executive officer, last listed Nov 2020) and Eric Tuveson (director, last listed Jun 2019).
Sources
- SECKyra Medical, Inc. Form D, filed Jun 13, 2024
- SECKyra Medical, Inc. Form D, filed Mar 24, 2022
- SECKyra Medical, Inc. Form D/A, filed Oct 13, 2020
- SECKyra Medical, Inc. Form D/A, filed Apr 16, 2020
- SECKyra Medical, Inc. Form D, filed Apr 15, 2020
- SECKyra Medical, Inc. Form D, filed May 4, 2017
- SECKyra Medical, Inc. filing history